| Note |
Depixol the first non-phenothiazine long-acting neuroleptic injection for patients suffering from schizophrenia. Lundbeck Limited are pleased to announce the introduction of Depixol. It has inherent antidepressant activity, lower incidence of side effects, duration of action 2-4 weeks. Depixol is an effective antipsychotic indicated in the management of schizphrenia patients, particularly those who are withdrawn, apathetic, or anergic. The incidence of side effects with Depixol appears to be less than with long-acting phenothiazines. |
